dimethyl fumarate Clinical Trials

3 actively recruiting trials across 1 location

▲ +1 trial since August 2026

Also known as: BG00012, DMF, Tecfidera

Pipeline

Phase 2: 2

Top Sponsors

Medical University of Lodz1
Guangzhou Lupeng Pharmaceutical Company LTD.1
Biogen1

Indications

Multiple Sclerosis2
Relapsing-remitting Multiple Sclerosis (RRMS)1
MCI-AD, Early Stage Alzheimer's Disease1
MCI1
Alzheimer's Disease1

Other2 trials

A Study of Rocbrutinib in PRL-Positive Relapsing-Remitting Multiple Sclerosis

Phase 2

Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease

Phase 2

Aurora, Colorado1 trial

Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)

University of Colorado Anschutz Medical Campus

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.